EcoR1 Capital’s Epizyme, Inc EPZM Stock Holding History

EcoR1 Capital’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-755,046	Closed	-$7.73M	–	41
2016 Q2	$7.73M	Sell	755,046 -843,854	-53%	-$9.41M	3.05%	12
2016 Q1	$19.4M	Buy	1,598,900 +900,000	+129%	+$9.1M	6.77%	3
2015 Q4	$11.2M	Sell	698,900 -793,800	-53%	-$11.8M	3.52%	11
2015 Q3	$19.2M	Sell	1,492,700 -193,100	-11%	-$3.9M	8.74%	5
2015 Q2	$40.5M	Buy	1,685,800 +105,400	+7%	+$2.03M	13.49%	2
2015 Q1	$29.7M	Buy	+1,580,400	New	+$32.6M	9.89%	2

Other funds holding EPZM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

EcoR1 Capital's EPZM Position: Q3 2016 in Review

EcoR1 Capital sold out of Epizyme, Inc (EPZM) in Q3 2016, closing a stake of 755,046 shares — an estimated $7.73M sold.

EcoR1 Capital first reported a position in EPZM in Q1 2015 and held it in 6 quarters. The position peaked at $40.5M in Q2 2015. 97 funds tracked by Wall St. Rank hold EPZM as of Q3 2016.

EcoR1 Capital reported no remaining Epizyme, Inc position as of Q3 2016 after selling out during the quarter.
EcoR1 Capital sold 755,046 Epizyme, Inc shares in Q3 2016, an estimated $7.73M.
EcoR1 Capital first reported a position in Epizyme, Inc in Q1 2015 and held it in 6 quarters.
EcoR1 Capital's Epizyme, Inc position peaked at $40.5M in Q2 2015.
97 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2016.

Based on EcoR1 Capital's 13F filing for Q3 2016, filed 14 Nov 2016.